Green Approaches to Peptide & Peptide–Oligo Conjugate Manufacturing
Sheri Ambriz, MBA
VP OF OLIGONUCLEOTIDE BUSINESS DEVELOPMENT
CPC SCIENTIFIC INC.
Sheri Ambriz, MBA
VP OF OLIGONUCLEOTIDE BUSINESS DEVELOPMENT
Presentation at TIDES USA 2025
Sheri Ambriz, MBA took the stage at TIDES USA 2025 in San Diego, CA, to share insights on green approaches to peptide and peptide–oligonucleotide conjugate manufacturing.
Key Highlights:
- Enhanced Atom Economy and Reduced Waste Generation
- Case Studies Showcasing Minimal Use of Protection Groups
- Innovative, Cost-Efficient Strategies for Manufacturing Peptide APIs and Oligo-Peptide Conjugates
Timestamps:
00:15 – Introduction (CPC Scientific)
00:40 – Agenda
1:11 – Components of a Peptide–Oligo Conjugate (POC)
2:30 – POC Linker Types
6:15 – Green Chemistry Goals in Peptide Manufacturing
13:24 – Minimal Protection Strategies
22:12 – Peptide–Oligo Conjugate Chemistry
31:03 – Summary & Concluding Thoughts
Don’t hesitate to reach out to us for a consultation or contact us at sales@cpcscientific.com. We’d love to continue the conversation.
Biography
Sheri Ambriz serves as the Vice President of Oligonucleotide Business Development at CPC Scientific. With over 25 years of experience spanning the life sciences, biotechnology, pharmaceutical, and CDMO sectors, she has held a range of leadership roles in process development, research and development, manufacturing, and business development. Sheri holds a B.S. in Biology from the University of California, Santa Cruz, and an MBA from San Francisco State University. She brings extensive expertise in oligonucleotide development and manufacturing, along with a proven track record of strategic leadership and industry insight.
